Escape mutants of HIV-1 proteinase: Enzymic efficiency and susceptibility to inhibition

被引:39
作者
Wilson, SI
Phylip, LH
Mills, JS
Gulnik, SV
Erickson, JW
Dunn, BM
Kay, J
机构
[1] UNIV WALES COLL CARDIFF, SCH MOL & MED BIOSCI, CARDIFF CF1 3US, S GLAM, WALES
[2] ROCHE RES CTR, WELWYN GARDEN CITY AL7 3AY, HERTS, ENGLAND
[3] NCI, FREDERICK CANC RES & DEV CTR, STRUCT BIOCHEM PROGRAM, FREDERICK, MD 21702 USA
[4] UNIV FLORIDA, J HILLIS MILLER HLTH CTR, DEPT BIOCHEM & MOL BIOL, GAINESVILLE, FL 32610 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY | 1997年 / 1339卷 / 01期
关键词
mutant HIV proteinase; HIV proteinase; substrate specificity; inhibitor binding; (E-coli);
D O I
10.1016/S0167-4838(96)00224-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Genes encoding a number of mutants of HIV-1 proteinase were sub-cloned and expressed in E. coli. The proteinases containing mutations of single residues (e.g., G48V, V82F, I84V and L90M) were purified and their catalytic efficiencies relative to that of wild-type proteinase were examined using a polyprotein (recombinant HIV-1 gag) substrate and several series of synthetic peptides based on the -Hydrophobic* Hydrophobic-, -Aromatic* Pro- and pseudo-symmetrical types of cleavage junction. The L90M proteinase showed only small changes, whereas the activity of the other mutant enzymes was compromised more severely, particularly towards substrates of the -Aromatic* Pro- and pseudo-symmetrical types The susceptibility of the mutants and the wild-type proteinase to inhibition by eleven different compounds was compared. The L90M proteinase again showed only marginal changes in its susceptibility to all except one of the inhibitors examined. The K-i values determined for one inhibitor (Ro31-8959) showed that its potency towards the V82F, L90M, I84V and G48V mutant proteinases respectively was 2-, 3-, 17- and 27-fold less than against the wild-type proteinase. Several of the other inhibitors examined form a systematic series with Ro31-8959. The inhibition constants derived with these and a number of other inhibitors, including ABT-538 and L-735,524, are used in conjunction with the data on enzymic efficiency to assess whether each mutation in the proteinase confers an advantage for viral replication in the presence of any given inhibitor.
引用
收藏
页码:113 / 125
页数:13
相关论文
共 40 条
  • [1] Natural variation in HIV-1 protease, gag p7 and p6, and protease cleavage sites within Gag/Pol polyproteins: Amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1
    Barrie, KA
    Perez, E
    Lamers, SL
    Farmerie, WG
    Dunn, BM
    Sleasman, JW
    Goodenow, MM
    [J]. VIROLOGY, 1996, 219 (02) : 407 - 416
  • [2] SUBREGIONS OF A CONSERVED PART OF THE HIV-GP41 TRANSMEMBRANE PROTEIN ARE DIFFERENTIALLY RECOGNIZED BY ANTIBODIES OF INFECTED INDIVIDUALS
    CERTA, U
    BANNWARTH, W
    STUBER, D
    GENTZ, R
    LANZER, M
    LEGRICE, S
    GUILLOT, F
    WENDLER, I
    HUNSMANN, G
    BUJARD, H
    MOUS, J
    [J]. EMBO JOURNAL, 1986, 5 (11) : 3051 - 3056
  • [3] IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS
    CONDRA, JH
    SCHLEIF, WA
    BLAHY, OM
    GABRYELSKI, LJ
    GRAHAM, DJ
    QUINTERO, JC
    RHODES, A
    ROBBINS, HL
    ROTH, E
    SHIVAPRAKASH, M
    TITUS, D
    YANG, T
    TEPPLER, H
    SQUIRES, KE
    DEUTSCH, PJ
    EMINI, EA
    [J]. NATURE, 1995, 374 (6522) : 569 - 571
  • [4] COOK ND, 1991, ADV EXP MED BIOL, V306, P525
  • [5] DISSOCIATION AND ASSOCIATION OF THE HIV-1 PROTEASE DIMER SUBUNITS - EQUILIBRIA AND RATES
    DARKE, PL
    JORDAN, SP
    HALL, DL
    ZUGAY, JA
    SHAFER, JA
    KUO, LC
    [J]. BIOCHEMISTRY, 1994, 33 (01) : 98 - 105
  • [6] MiniReview: Antiviral Targets Series, Number 1 Targets for antiviral chemotherapy: HIV-proteinase
    Dunn, B. M.
    Kay, J.
    [J]. ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1990, 1 (01) : 3 - 8
  • [7] DUNN BM, 1994, METHOD ENZYMOL, V241, P254
  • [8] THE NOT-SO-GREAT ESCAPE
    ERICKSON, JW
    [J]. NATURE STRUCTURAL BIOLOGY, 1995, 2 (07): : 523 - 529
  • [9] DIFFERENT REQUIREMENTS FOR PRODUCTIVE INTERACTION BETWEEN THE ACTIVE-SITE OF HIV-1 PROTEINASE AND SUBSTRATES CONTAINING -HYDROPHOBIC-ASTERISK HYDROPHOBIC- OR -AROMATIC-ASTERISK PRO- CLEAVAGE SITES
    GRIFFITHS, JT
    PHYLIP, LH
    KONVALINKA, J
    STROP, P
    GUSTCHINA, A
    WLODAWER, A
    DAVENPORT, RJ
    BRIGGS, R
    DUNN, BM
    KAY, J
    [J]. BIOCHEMISTRY, 1992, 31 (22) : 5193 - 5200
  • [10] GRIFFITHS JT, 1994, J BIOL CHEM, V269, P4787